“Long-Term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics”. 2019. SKIN The Journal of Cutaneous Medicine 3 (November): S22. https://doi.org/10.25251/skin.3.supp.22.